- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-11-0002905

About Zeiss Pharmaceuticals Private Limited
Data last updated:
Zeiss Pharmaceuticals Private Limited is a private limited company based in Nalagarh, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 March 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24200HP2004PTC026909. Its GSTIN is 02AAACZ2089F1ZI (Himachal Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.4 Lakh. It is led by directors including Sat Pal and Vikas Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nalagarh, Himachal Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹96.9 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹27.4 Cr (net margin 28.3%) and EBITDA of ₹48.31 Cr (EBITDA margin 49.9%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 13% over five years.
The company has about 101 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹200.23 Cr and satisfied charges of ₹9.83 Cr on record. Court records list 5 cases involving the company, including 2 filed by the company and 3 filed against it; 2 cases are pending. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹2.35 Cr; the latest was in June 2023. Its 6 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Arene Life Sciences (Unit 4) Private Limited with revenue of ₹405.87 Cr. The company has 7 MSME Form 1 returns on record between 2019 and 2022, listing 788 overdue payments to 45 micro and small suppliers.
Zeiss Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0002905). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zeisspharma.com.
Company details
Recognitions & Rankings of Zeiss Pharmaceuticals
Contact details
Zeiss Pharmaceuticals Private Limited's registered office is in Nalagarh, Himachal Pradesh. Its website is zeisspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 72 – 73 Epip Pahse – I, Near Esi Dispensary Jharmajai Baddi Solan, Nalagarh, Himachal Pradesh, India – 173205
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Zeiss Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zeiss Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Zeiss Pharmaceuticals Private Limited, buy the company report.
Financials of Zeiss Pharmaceuticals Private Limited
FY 2025 filings availableZeiss Pharmaceuticals Private Limited reported revenue of ₹96.9 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 6% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹96.9 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹48.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹27.4 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 49.9% | ||||
| Net Profit Margin | 28.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zeiss Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zeiss Pharmaceuticals Private Limited
Zeiss Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sat Pal Also directs: Zeiss Pharma Limited | Director | 11 Mar 2004 | 22 Years 7 Months | Current |
| Vikas Gupta Also directs: Zeiss Pharma Limited, Mczeiss Life Science LLP | Director | 11 Mar 2004 | 22 Years 7 Months | Current |
| Vinij Gupta Also directs: Zeiss Pharma Limited | Director | 11 Mar 2004 | 22 Years 7 Months | Current |
Peer comparison
Zeiss Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arene Life Sciences (Unit 4) Private Limited | ₹405.87 Cr (FY 2021) | 3.0% | Hyderabad, Telangana, India | |||
| United Biotech Private Limited | ₹404.94 Cr (FY 2024) | 27.0% | New Delhi, Delhi, India | |||
| Torque Pharmaceuticals Private Limited | ₹404.13 Cr (FY 2024) | 1.0% | Chandigarh, India | |||
| Steril-Gene Life Sciences Private Limited | ₹404.06 Cr (FY 2025) | 41.0% | Chennai, Tamil Nadu, India | |||
| Gland Chemicals Pvt Ltd | ₹401.18 Cr (FY 2022) | 33.0% | Hyderabad, Telangana, India | |||
| Maiva Pharma Private Limited | ₹399.05 Cr (FY 2025) | 38.0% | Bangalore, Karnataka, India | |||
| Zeiss Pharmaceuticals Private Limitedthis company | ₹96.9 Cr (FY 2025) | ₹27.4 Cr | 28.3% | 6.0% | 101 | Nalagarh, Himachal Pradesh, India |
To see the full peer comparison of Zeiss Pharmaceuticals Private Limited, buy the company report.
Auditor
Zeiss Pharmaceuticals Private Limited is audited by VINEY GOEL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VINEY GOEL & ASSOCIATES | FY 2023 | 012188N |
Shareholding
The shareholding of Zeiss Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zeiss Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Mar 2024 | 100875705 | Hdfc Bank Limited | ₹10 Cr | Open | |
| 10 Feb 2024 | 100881385 | Hdfc Bank Limited | ₹10 Cr | Open | |
| 19 Dec 2015 | 10614312 | Hdfc Bank Limited | ₹180.23 Cr | Open | |
| 30 Jul 2008 | 10121371 | Axis Bank Limited | ₹4.25 Cr | Satisfied | |
| 18 Aug 2007 | 10068942 | Member Secretary | ₹2.33 Cr | Satisfied |
To see the full charge records of Zeiss Pharmaceuticals Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Zeiss Pharmaceuticals Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹2.35 Cr; the latest was in June 2023.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Sbjb Dynasty Trust |
| Jun 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Sbjb Dynasty Trust |
| Jun 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Sbjb Dynasty Trust |
| Nov 2018 | Secondary share transfer | Undisclosed | Buyer: Sbjb Dynasty Trust Seller: an individual |
| Apr 2007 | Funding round | ₹1.32 Cr | Investors: an individual |
To see the full deal history of Zeiss Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Zeiss Pharmaceuticals Private Limited has 5 court cases on record: 2 filed by Zeiss Pharmaceuticals, 3 filed against it. 2 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 1 | 1 |
| District courts | 2 | 2 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Court case (TM) | Filed against the company by Ms Brawn Laboratories Ltd | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by M/S Brawn Laboratories Ltd | Disposed |
| High Court, ANDHRAPRADESH | Court case (CRLP) | Filed by the company against individuals | Pending |
| District court, Chittoor, Andhra Pradesh | Criminal complaint | Filed against the company by The Drug Inspector, the State of Andhra Pradesh, Tirupati Urban | Pending |
| High Court, JAMMU & KASHMIR | Court case (CRTA) | Filed by the company against State of JK and Others | Disposed |
To see the full case history of Zeiss Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Zeiss Pharmaceuticals Private Limited has 7 MSME Form 1 returns on record between 2019 and 2022, listing 788 overdue payments to 45 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 45)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Axenic Print Pack | |||
| Kartonz | |||
| Artpack Industries | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Zeiss Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Zeiss Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Zeiss Pharma Limited | U24233HR2014PLC052139 |
To see the full group structure of Zeiss Pharmaceuticals Private Limited, buy the company report.
Employees & EPFO
Zeiss Pharmaceuticals Private Limited has a workforce of 101 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
GST
Zeiss Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAACZ2089F1ZI | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Zeiss Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zeiss Pharmaceuticals Private Limited has 3 board changes on record since 2004: 3 appointments. The latest: Sat Pal was appointed as Director on 11 Mar 2004.
6 earlier events are in the company report.
Frequently asked questions
Zeiss Pharmaceuticals is an active private limited company based in Nalagarh, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 March 2004 (22+ years old) and is registered under CIN U24200HP2004PTC026909.
Zeiss Pharmaceuticals has 3 current directors:
- Sat Pal - Director
- Vikas Gupta - Director
- Vinij Gupta - Director
The latest financial statements of Zeiss Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Zeiss Pharmaceuticals is 02AAACZ2089F1ZI, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Zeiss Pharmaceuticals is U24200HP2004PTC026909. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zeiss Pharmaceuticals has 5 court cases on record: 2 filed by the company and 3 filed against it. 2 are pending. Most are in the high courts.
Zeiss Pharmaceuticals was incorporated on 11 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Zeiss Pharmaceuticals has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹2.35 Cr; the latest was in June 2023.
The peers of Zeiss Pharmaceuticals by revenue are Arene Life Sciences (Unit 4) Private Limited, United Biotech Private Limited, Torque Pharmaceuticals Private Limited, Steril-Gene Life Sciences Private Limited, Gland Chemicals Pvt Ltd and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sat Pal was appointed as Director on 11 Mar 2004. Vikas Gupta was appointed as Director on 11 Mar 2004. Vinij Gupta was appointed as Director on 11 Mar 2004.
Yes, Zeiss Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0002905).
Zeiss Pharmaceuticals has 7 MSME Form 1 returns on record between 2019 and 2022, listing 788 overdue payments to 45 micro and small suppliers. The latest return was filed on 15 Nov 2022.

